Davita Healthcare Partners Inc (DVA) Stock Price, Quote & News

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administ...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 720 631 2100

Website: www.davita.com

Address:

2000 16th Street, Denver, United States

Noname2022 Aug. 18 at 1:52 AM

$CRMD $DVA $FMS DaVita introduced ClearGuard HD in May 2019 as “standard of care for CVC patients.” Now CorMedix says upcoming data “will highlight the demonstrated efficacy of DefenCath when used in combination with chlorhexidine antimicrobial caps.” If durable Medicare Advantage reimbursement is secured in early 2027, does DefenCath eventually follow ClearGuard’s path at DaVita? https://stockanalysis.com/stocks/crmd/transcripts/669135-q2-2026/ https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083

1 · Reply

wolfofwestloop Aug. 17 at 9:47 AM

$CRMD Joe's excitement level on the ER call after announcing they just signed an agreement with $DVA and they have $250M in cash on hand.

0 · Reply

Noname2022 Aug. 15 at 3:43 PM

$CRMD $DVA

1 · Reply

Bazziggr Aug. 14 at 11:26 AM

$DVA this is ridiculous

0 · Reply

Noname2022 Aug. 14 at 2:07 AM

DaVita’s $DVA Vafseo $AKBA rollout : • 100+ clinic pilot began 8/18/25 • Went “village-wide” on 11/10/25 • Pilot to village-wide access: 84 days Why this matters for $CRMD: • Similar timing could put DefenCath village-wide before potential MA contracts begin in early 2027 • That is a strong setup for $FMS -like adoption *Not a direct adoption comparison. Vafseo faced adherence issues, protocol changes, anemia-manager concerns, and decades of ESA inertia. Access did not equal immediate utilization.

4 · Reply

Noname2022 Aug. 13 at 10:20 PM

Reminder: comments on CMS’s CY2027 ESRD rule remain open through Aug. 24. On $DVA’s Q2 call, CEO Javier Rodriguez said: “The net result is a rate increase that once again tracks below the cost trends for the industry. We’re providing feedback during the rulemaking process.” Separately for $CRMD, the same rule estimates a $5.5951/treatment DefenCath add-on for 2027 and proposes quarterly recalculation using updated utilization and ASP data. No DaVita-authored comment is publicly visible yet. https://stockanalysis.com/stocks/dva/transcripts/660921-q2-2026/ https://www.federalregister.gov/documents/2026/06/26/2026-12925/medicare-program-cy-2027-changes-to-the-end-stage-renal-disease-esrd-prospective-payment-system

0 · Reply

Noname2022 Aug. 13 at 12:23 PM

$AKBA $DVA $CRMD $FMS Amazing how the Davita CMO can impact patient care! (Forbes this week) https://www.forbes.com/councils/forbesbusinesscouncil/2026/08/12/leaving-the-bedside-doesnt-mean-leaving-patients-behind/

0 · Reply

Noname2022 Aug. 13 at 11:48 AM

$AKBA $DVA $CRMD $FMS Davita is amazing company that truly cares about savings patients from preventable CBRSI infections! *2nd leading cause of mortality in dialysis Pilot starts Q3 😁 https://www.globenewswire.com/news-release/2026/08/13/3344407/0/en/cormedix-therapeutics-reports-second-quarter-2026-financial-results-and-provides-business-update.html

3 · Reply

Bazziggr Aug. 11 at 5:16 PM

$DVA few more

0 · Reply

Intuitive_Investing Aug. 11 at 4:32 PM

$DVA Sorted at 235 covered 180. Will re-short if goes above 190

0 · Reply

DaVita flags lower revenue per treatment, reaffirms annual forecast

Aug 4, 2026, 5:00 PM EDT - 14 days ago

DaVita Earnings Call Transcript: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 14 days ago

DaVita Earnings release: Q2 2026

Aug 4, 2026, 5:00 PM EDT - 14 days ago

DaVita Quarterly report: Q2 2026

Aug 4, 2026, 4:05 PM EDT - 14 days ago

DaVita Inc. 2nd Quarter 2026 Results

Jul 21, 2026, 5:00 PM EDT - 4 weeks ago

DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

May 18, 2026, 3:00 PM EDT - 3 months ago

DaVita Sets Bold 2030 Community Care Commitments After Exceeding Prior Five-Year ESG Goals

May 12, 2026, 5:20 PM EDT - 3 months ago

DaVita Transcript: Bank of America Global Healthcare Conference 2026

May 6, 2026, 6:01 PM EDT - 3 months ago

DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference

May 5, 2026, 5:31 PM EDT - 3 months ago

DaVita lifts annual profit forecast on strong demand for dialysis services

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 3 months ago

DaVita Quarterly report: Q1 2026

May 5, 2026, 4:05 PM EDT - 3 months ago

DaVita Inc. 1st Quarter 2026 Results

Apr 28, 2026, 7:00 AM EDT - 4 months ago

Honeywell Announces Board of Directors for Honeywell Aerospace

HON

Apr 22, 2026, 8:00 AM EDT - 4 months ago

DaVita Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 months ago

DaVita Proxy statement: Proxy filing

Apr 20, 2026, 2:06 PM EDT - 4 months ago

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call

Mar 18, 2026, 3:00 PM EDT - 5 months ago

DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement

Mar 17, 2026, 7:00 AM EDT - 5 months ago

R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease

Mar 2, 2026, 11:50 AM EST - 6 months ago

DaVita Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 2:00 PM EST - 6 months ago

DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference

Feb 11, 2026, 10:45 AM EST - 6 months ago

20 stocks of companies that delivered a double dose of growth this earnings season

APH BA CAH FICO GLW GOOG GOOGL

Feb 3, 2026, 11:00 AM EST - 7 months ago

TER Quarterly Sales Top $1B, DVA & PEP Beat Earnings

PEP TER

Feb 2, 2026, 5:06 PM EST - 7 months ago

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Earnings Call Transcript: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Annual report: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Earnings release: Q4 2025

Feb 2, 2026, 5:00 PM EST - 7 months ago

DaVita Annual report: Q4 2025

Feb 2, 2026, 4:05 PM EST - 7 months ago

DaVita Inc. 4th Quarter 2025 Results

Jan 21, 2026, 10:00 AM EST - 7 months ago

DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call

Dec 11, 2025, 8:00 AM EST - 8 months ago

DaVita Names New Leaders to Accelerate Care Transformation

Nov 17, 2025, 11:20 AM EST - 9 months ago

DaVita Transcript: Wolfe Research Healthcare Conference 2025

Nov 14, 2025, 4:16 PM EST - 9 months ago

DaVita Inc. to Participate in Fireside Chat with Wolfe Research

Nov 4, 2025, 8:00 AM EST - 10 months ago

DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025

Oct 29, 2025, 5:32 PM EDT - 10 months ago

DaVita misses quarterly profit estimates on rising costs, lower volumes

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Earnings Call Transcript: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Quarterly report: Q3 2025

Oct 29, 2025, 5:00 PM EDT - 10 months ago

DaVita Earnings release: Q3 2025

Oct 29, 2025, 4:05 PM EDT - 10 months ago

DaVita Inc. 3rd Quarter 2025 Results

Oct 20, 2025, 8:00 AM EDT - 10 months ago

DaVita Leads the Way in Evaluating Middle Molecule Clearance with Two New Initiatives

Oct 13, 2025, 2:00 PM EDT - 11 months ago

DaVita Inc. Schedules 3rd Quarter 2025 Investor Conference Call

Aug 27, 2025, 8:00 AM EDT - 1 year ago

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Aug 21, 2025, 5:59 PM EDT - 1 year ago

Ransomware attack at dialysis firm DaVita affects 2.7 million people, US health dept website shows

Aug 5, 2025, 5:15 PM EDT - 1 year ago

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Quarterly report: Q2 2025

Aug 5, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings release: Q2 2025

Aug 5, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 2nd Quarter 2025 Results

Jul 17, 2025, 5:37 PM EDT - 1 year ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jun 2, 2025, 12:15 PM EDT - 1 year ago

20 stocks primed for rapid growth while trading at half of Nvidia's valuation

AIG APTV BALL CTRA DELL ELV EQT

May 30, 2025, 2:35 PM EDT - 1 year ago

DaVita Statement on Government's Kidney Care Choices (KCC) Model Updates

May 20, 2025, 4:42 PM EDT - 1 year ago

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

May 20, 2025, 9:05 AM EDT - 1 year ago

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

May 20, 2025, 8:51 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $750 Million Senior Notes

May 12, 2025, 5:37 PM EDT - 1 year ago

DaVita beats quarterly profit estimates amid stable demand for dialysis services

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings Call Transcript: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Quarterly report: Q1 2025

May 12, 2025, 5:00 PM EDT - 1 year ago

DaVita Earnings release: Q1 2025

May 12, 2025, 4:51 PM EDT - 1 year ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:05 PM EDT - 1 year ago

DaVita Inc. 1st Quarter 2025 Results

Apr 30, 2025, 11:00 AM EDT - 1 year ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

Apr 24, 2025, 8:00 AM EDT - 1 year ago

DaVita Proxy statement: Proxy Filing

Apr 14, 2025, 7:35 AM EDT - 1 year ago

DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:33 AM EDT - 1 year ago

Dialysis firm DaVita hit by ransomware attack

Mar 31, 2025, 7:35 AM EDT - 1 year ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX COR

Mar 11, 2025, 9:00 AM EDT - 1 year ago

DaVita Transcript: Barclays 27th Annual Global Healthcare Conference

Mar 6, 2025, 10:00 AM EST - 1 year ago

DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

Feb 27, 2025, 9:00 AM EST - 1 year ago

YMCA of the USA Deepens Collaboration with DaVita to Drive Kidney Health Initiatives in Seven Communities

Feb 19, 2025, 8:05 PM EST - 1 year ago

Berkshire Hathaway sells another 750,000 DaVita shares

Feb 14, 2025, 1:01 PM EST - 1 year ago

DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Feb 14, 2025, 8:16 AM EST - 1 year ago

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

Feb 13, 2025, 8:13 PM EST - 1 year ago

Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 6:07 PM EST - 1 year ago

DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings Call Transcript: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Annual report: Q4 2024

Feb 13, 2025, 5:00 PM EST - 1 year ago

DaVita Earnings release: Q4 2024

Feb 13, 2025, 4:05 PM EST - 1 year ago

DaVita Inc. 4th Quarter 2024 Results

Jan 30, 2025, 11:55 AM EST - 1 year ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Noname2022 Aug. 18 at 1:52 AM

1 · Reply

wolfofwestloop Aug. 17 at 9:47 AM

$CRMD Joe's excitement level on the ER call after announcing they just signed an agreement with $DVA and they have $250M in cash on hand.

0 · Reply

Noname2022 Aug. 15 at 3:43 PM

$CRMD $DVA

1 · Reply

Bazziggr Aug. 14 at 11:26 AM

$DVA this is ridiculous

0 · Reply

Noname2022 Aug. 14 at 2:07 AM

4 · Reply

Noname2022 Aug. 13 at 10:20 PM

0 · Reply

Noname2022 Aug. 13 at 12:23 PM

0 · Reply

Noname2022 Aug. 13 at 11:48 AM

3 · Reply

Bazziggr Aug. 11 at 5:16 PM

$DVA few more

0 · Reply

Intuitive_Investing Aug. 11 at 4:32 PM

$DVA Sorted at 235 covered 180. Will re-short if goes above 190

0 · Reply

Intuitive_Investing Aug. 11 at 1:22 AM

$DVA Classic financial engineering on $DVA. Incurred a brand new $500M Term Loan B-2 just to shuffle debt around and turn around to blow cash repurchasing 2.2M shares at a whopping $154.95 average price. Paying down debt? Nope. propping up the stock while patients bleed out. Short printing! 🩸🐖

0 · Reply

Intuitive_Investing Aug. 11 at 1:07 AM

$DVA Short $DVA. The balance sheet is a debt-loaded mess. They've spent years bleeding patients and suffocating emerging medical tech innovation. Fade it! 🐻

1 · Reply

jd4308 Aug. 10 at 11:56 AM

$DVA ENTRY TODAY @ 183.72 ...GAP FILLED ....KEY LEVELS HOLDING ....WILL RETEST THE $194 LEVEL

2 · Reply

WhoKnocks Aug. 9 at 2:14 AM

$DVA ok. I’ve convinced myself this is worth some investment. I get the reasons it got hit but I think it’s way over done. Hopefully the market eventually agrees with me.

1 · Reply

Noname2022 Aug. 8 at 8:56 PM

$AKBA $DVA Gosh! Why are DaVita doctors such idiots? They could just prescribe Vafseo faster and make the stock go up. Freakin’ idiots.

1 · Reply

TheGOATofTrading Aug. 8 at 4:25 PM

$BRK.B $DVA Best idea: Davita just lost 25% of market cap after decent earnings. Buffet owns 47%. Aggressive Share buy back has reduced Outstanding shares by 70% in past 10 years.

1 · Reply